Meetings - The ASCO Post

/ Integrating Targeted Therapies in mHSPC A Changing Treatment Landscape

Case 3: <em>BRCA</em>-Mutated Metastatic Prostate Cancer

This is Part 3 of Integrating Targeted Therapies in mHSPC: A Changing Treatment Landscape, a three-part video roundtable series. Scroll down to watch the other videos from this roundtable. In this ...

prostate cancer

/ Integrating Targeted Therapies in mHSPC A Changing Treatment Landscape

Case 2: PTEN-Deficient Metastatic Prostate Cancer

This is Part 2 of Integrating Targeted Therapies in mHSPC: A Changing Treatment Landscape, a three-part video roundtable series. Scroll down to watch the other videos from this roundtable. In this ...

prostate cancer

/ Integrating Targeted Therapies in mHSPC A Changing Treatment Landscape

Case 1: PSMA PET–Positive Metastatic Prostate Cancer

This is Part 1 of Integrating Targeted Therapies in mHSPC: A Changing Treatment Landscape, a three-part video roundtable series. Scroll down to watch the other videos from this roundtable. In this v...

Integrating Targeted Therapies in mHSPC A Changing Treatment Landscape

Case 3: <em>BRCA</em>-Mutated Metastatic Prostate Cancer

Case 2: PTEN-Deficient Metastatic Prostate Cancer

Case 1: PSMA PET–Positive Metastatic Prostate Cancer

AI-Derived Bone Marrow Architecture Score Improves Disease Assessment in Myelodysplastic Neoplasms

Multiple Myeloma Studies Highlight Advances Across the Field

Early Research Examines Daraxonrasib in NRAS-Mutant Melanoma

Can Consolidative Thoracic Radiotherapy Improve Outcomes During Immunotherapy Maintenance in Extensive-Stage SCLC?

Treatment Delays May Increase Metastasis Risk in Nonmetastatic Colorectal Cancer